Ayman Alsheikh | Medical Microbiology | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Ayman Alsheikh
Zarqa University, Jordan

Ayman Alsheikh
Affiliation Zarqa University
Country Jordan
Scopus ID 55391661100
Documents 18
Citations 47
h-index 4
Subject Area Medical Microbiology
Event Health Scientists Awards
ORCID 0000-0002-1151-1178

The Best Researcher Award recognizes distinguished academic contributions in Medical Microbiology through impactful research, scholarly publications, and scientific engagement. Ayman Alsheikh of Zarqa University has contributed to advancing microbiological research through peer-reviewed publications and collaborative scientific activities. His academic profile demonstrates sustained involvement in medical microbiology and related health sciences disciplines, supporting knowledge generation and evidence-based scientific development.[1]

Abstract

Ayman Alsheikh is a researcher affiliated with Zarqa University whose scholarly activities are centered on Medical Microbiology and related health science disciplines. His research portfolio includes investigations addressing microbial pathogens, infection mechanisms, public health concerns, and laboratory-based scientific studies. Through peer-reviewed publications and academic collaborations, he has contributed to the dissemination of scientific knowledge supporting evidence-based healthcare practices. His documented research output, citation record, and engagement with international scholarly databases demonstrate continued participation in microbiological research and scientific communication. These contributions reflect a commitment to advancing research quality and academic excellence within the medical sciences.[1]

Keywords

Medical Microbiology, Infectious Diseases, Clinical Microbiology, Bacterial Pathogens, Public Health, Microbial Research, Laboratory Science, Healthcare Research, Epidemiology, Health Sciences

Introduction

Medical microbiology plays a vital role in understanding infectious diseases and improving healthcare outcomes. Ayman Alsheikh has participated in research activities that support scientific understanding of microorganisms and their impact on human health. His academic work contributes to ongoing efforts aimed at strengthening evidence-based medical research and laboratory sciences.[1]

Research Profile

Affiliated with Zarqa University, Ayman Alsheikh maintains a research profile focused on Medical Microbiology. His scholarly record includes 18 indexed documents, 47 citations, and an h-index of 4. These metrics reflect active engagement in scientific publishing and participation in internationally recognized academic research platforms.[3]

Research Contributions

His contributions include studies related to microbial pathogens, laboratory investigations, and health-related scientific analysis. Through collaborative and independent research efforts, he has supported the generation of knowledge relevant to microbiological sciences, helping strengthen academic understanding of infectious disease processes and microbial interactions.[1]

Publications

The researcher has produced multiple peer-reviewed publications indexed within major academic databases. His publication portfolio demonstrates consistent involvement in microbiology research and scientific communication. Published works contribute to the broader dissemination of findings relevant to healthcare, microbiological investigations, and biomedical research advancement.[1]

Research Impact

The citation performance associated with his publications indicates scholarly recognition within the scientific community. His research contributes to the evidence base supporting microbiological studies and healthcare-related investigations. Continued citation activity reflects the relevance of his published work to researchers, educators, and health science professionals.[2]

Award Suitability

Ayman Alsheikh demonstrates characteristics commonly associated with Best Researcher Award recognition, including scientific productivity, peer-reviewed publications, measurable citation impact, and engagement in Medical Microbiology research. His documented academic contributions and commitment to scholarly advancement align with evaluation criteria emphasizing research quality, relevance, and academic excellence.[4]

Conclusion

The academic record of Ayman Alsheikh reflects sustained participation in Medical Microbiology research and scholarly publishing. Through scientific contributions, publication activity, and engagement with international research platforms, he continues to support knowledge development within health sciences. His profile illustrates a meaningful contribution to contemporary microbiological research.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Ayman Alsheikh, Author ID 55391661100. Scopus.https://www.scopus.com/authid/detail.uri?authorId=55391661100
  2. ORCID. (n.d.). ORCID record for Ayman Alsheikh.https://orcid.org/0000-0002-1151-1178
  3. Google Scholar. (n.d.). Scholar profile and citation metrics.https://scholar.google.com/citations?user=mER-WC4AAAAJ&hl=en
  4. ResearchGate. (n.d.). Ayman Alsheikh research profile and publication overview.https://www.researchgate.net/profile/Ayman-Alsheikh
  5. Health Scientists Awards. (n.d.). Award information and evaluation criteria.https://healthscientists.org/

Hongguang Nie | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hongguang Nie
China Medical University

Hongguang Nie
Affiliation China Medical University
Country China
Scopus ID 7103200378
Documents 69
Citations 1143
h-index 17
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-9973-6354

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained impact within their scientific disciplines. Hongguang Nie of China Medical University has established a notable research profile in infectious diseases through peer-reviewed publications, citation influence, and interdisciplinary collaboration. His research activities have contributed to advancing knowledge related to infectious disease mechanisms, clinical outcomes, epidemiology, and healthcare improvement initiatives. The academic record represented through indexed publications and citation metrics reflects continuing engagement with scientific inquiry and evidence-based healthcare research.[1]

Abstract

Hongguang Nie is a researcher affiliated with China Medical University whose scholarly activities are focused primarily on infectious diseases and related biomedical investigations. His publication portfolio demonstrates engagement with epidemiology, disease mechanisms, clinical research, public health applications, and healthcare outcomes. With a documented record of 69 indexed publications, 1,143 citations, and an h-index of 17, his work has achieved measurable visibility within the scientific community. The breadth of his contributions reflects sustained participation in evidence-based research, interdisciplinary collaboration, and the dissemination of findings that support improved understanding of infectious disease challenges and healthcare advancement.[1]

Keywords

Infectious Diseases, Epidemiology, Clinical Research, Public Health, Disease Prevention, Healthcare Outcomes, Biomedical Science, Medical Research, Infection Control, Translational Medicine

Introduction

Research in infectious diseases remains essential for understanding pathogen transmission, disease progression, prevention strategies, and clinical interventions. Hongguang Nie has contributed to this field through scholarly publications that support evidence-based medical knowledge and healthcare improvement. His research activities align with contemporary priorities in disease control, epidemiology, and public health advancement.[2]

Research Profile

Hongguang Nie is affiliated with China Medical University and maintains an active research profile within infectious diseases. His scholarly record includes peer-reviewed publications indexed in international databases, demonstrating ongoing participation in biomedical research. Citation performance and publication productivity indicate sustained engagement with scientific investigation and collaborative academic endeavors.[1]

Research Contributions

The research contributions of Hongguang Nie encompass infectious disease studies, clinical investigations, healthcare outcome assessments, and epidemiological analyses. His publications have supported understanding of disease-related challenges and informed evidence-based approaches in medical science. Collaborative research efforts further demonstrate his commitment to advancing knowledge through multidisciplinary scientific inquiry.[3]

Publications

The publication record associated with Hongguang Nie includes articles published in recognized scientific journals addressing infectious diseases and related healthcare topics. These works contribute to the dissemination of research findings and facilitate scholarly dialogue. Indexed publications and associated citations reflect the visibility and relevance of his research outputs within the academic community.[1]

Research Impact

Research impact can be evaluated through publication influence, citation metrics, and scholarly engagement. With more than one thousand citations and a measurable h-index, Hongguang Nie’s work demonstrates recognition within relevant research communities. His studies contribute to the broader scientific understanding of infectious diseases and support ongoing developments in healthcare research.[1]

Award Suitability

Hongguang Nie’s scholarly achievements, publication record, citation performance, and research focus in infectious diseases align with the objectives of the Innovative Research Award. His demonstrated commitment to scientific investigation and knowledge dissemination supports consideration for recognition within the Health Scientists Awards framework and related academic evaluation processes.[1]

Conclusion

Hongguang Nie has developed a credible academic profile through sustained contributions to infectious disease research. His publication output, citation record, and engagement in scientific collaboration illustrate continued involvement in advancing medical knowledge. These accomplishments support recognition within academic award programs dedicated to research excellence and healthcare innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hongguang Nie, Author ID 7103200378. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7103200378
  2. Xin, S., Ding, Y., Yu, T., et al. (2025). Mesenchymal Stem Cell-Secreted KGF Ameliorates Acute Lung Injury via the Gab1/ERK/NF-κB Signaling Axis. https://pubmed.ncbi.nlm.nih.gov/40640718/
  3. Li, X., Fu, Y., Yu, T., Song, R., Nie, H., & Ding, Y. (2025). Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology.     https://pubmed.ncbi.nlm.nih.gov/41011200

Kenjiro Nagai | Infectious Diseases | Research Excellence Award

Published on by Health Scientists

Research Excellence Award

Kenjiro Nagai
Ebina Centro Clinic, Japan

Kenjiro Nagai
Affiliation Ebina Centro Clinic
Country Japan
Scopus ID 56915217000
Documents 20
Citations 585
h-index 12
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-7726-7403

Kenjiro Nagai is a researcher affiliated with Ebina Centro Clinic whose scholarly work has contributed to the field of infectious diseases. His publication record, citation performance, and documented research activities demonstrate sustained engagement in clinical and scientific investigations relevant to disease prevention, diagnosis, treatment, and healthcare outcomes. The following article provides a structured overview of his research profile and potential suitability for recognition through the Health Scientists Awards.[1]

Abstract

Kenjiro Nagai has established a research profile centered on infectious diseases and clinically relevant healthcare investigations. His scholarly contributions encompass disease surveillance, patient management strategies, diagnostic evaluation, and evidence-based medical practice. Through a portfolio of peer-reviewed publications and measurable citation influence, his work has supported scientific understanding and practical healthcare applications. The documented research output reflects continuous engagement with contemporary challenges in infectious disease medicine. Bibliometric indicators, including citation performance and h-index, suggest sustained academic visibility. These accomplishments position his research activities as relevant to professional recognition within international scientific and healthcare award frameworks.[1][2]

Keywords

  • Infectious Diseases
  • Clinical Research
  • Disease Prevention
  • Epidemiology
  • Medical Science
  • Patient Care
  • Public Health
  • Health Research

Introduction

The field of infectious diseases remains essential for improving global health outcomes and strengthening healthcare systems. Researchers working within this discipline contribute to understanding disease transmission, treatment approaches, and preventive strategies. Kenjiro Nagai’s scholarly activities align with these objectives through clinically focused investigations and scientific dissemination.[1]

Research Profile

Affiliated with Ebina Centro Clinic in Japan, Kenjiro Nagai has developed a publication record comprising twenty indexed documents. His citation count and h-index indicate continuing academic engagement and recognition within relevant scientific communities focused on infectious diseases and healthcare research.[1]

Research Contributions

His contributions support the advancement of infectious disease knowledge through clinical observations, evidence generation, and publication of findings relevant to patient care. Such efforts contribute to broader scientific understanding and may assist healthcare professionals in informed clinical decision-making processes.[2]

Publications

The documented publication portfolio includes peer-reviewed research articles associated with infectious disease investigations. These works have generated measurable scholarly attention through citations and demonstrate participation in scientific communication, knowledge dissemination, and ongoing engagement with healthcare research topics.[1]

Research Impact

Bibliometric indicators suggest that Kenjiro Nagai’s research has achieved visibility within academic literature. Citation accumulation reflects scholarly use of published findings, while the h-index demonstrates a consistent level of influence across multiple research outputs within the infectious diseases domain.[1]

Award Suitability

Based on available research metrics, publication activity, and subject specialization, Kenjiro Nagai demonstrates characteristics commonly evaluated in scientific recognition programs. His documented contributions to infectious disease research align with the objectives of awards honoring healthcare innovation and scientific advancement.[3]

Conclusion

Kenjiro Nagai’s academic record reflects meaningful engagement in infectious disease research and clinical scholarship. His publication achievements, citation impact, and professional contributions collectively indicate a sustained commitment to advancing medical knowledge and supporting evidence-based healthcare practices.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kenjiro Nagai, Author ID 56915217000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56915217000

  2. Nagai, K., Nagai, S., et al. (2025). Report on Successful Treatment of Refractory MAC Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.

    https://doi.org/10.1016/S1473-3099(20)30154-9

  3. Health Scientists Awards. Award evaluation framework and recognition objectives.https://healthscientists.org/

Wenxin Xue | Public Health | Best Researcher Award

Published on by Health Scientists

Prof. Wenxin Xue | Public Health | Best Researcher Award

clinical pharmacist | Emergency General Hospital | China

Wenxin Xue is a distinguished chief pharmacist and pharmacology scholar whose career reflects a sustained commitment to advancing evidence-based clinical pharmacy, interdisciplinary healthcare, and translational pharmacological research. With a strong foundation as a PhD-trained pharmacologist, clinical pharmacist, graduate tutor, and head of a clinical pharmacy group, he has contributed extensively to optimizing therapeutic strategies, enhancing medication safety, and improving patient outcomes across complex clinical settings. His expertise spans vascular pharmacology, endocrine-metabolic disorders, renal protection, infectious disease therapeutics, immune-oncology, and health technology assessment, demonstrated through a substantial portfolio of peer-reviewed publications with significant citation visibility and coverage across both basic and clinical research. His scholarly work includes investigations on endothelial dysfunction, adrenergic receptor mechanisms, statin therapy, immune checkpoint inhibitor outcomes, infectious disease precision medication, adverse reaction surveillance, and meta-analytic evaluations of therapeutic efficacy, all of which have supported improved clinical decision-making and policy development. As a reviewer and editorial board member for multiple international and national journals, he plays a key role in shaping scientific discourse and ensuring research quality, while his involvement in multidisciplinary teams for weight management, geriatrics, and infectious diseases highlights his leadership in collaborative, patient-centered care. His research initiatives integrate pharmacodynamics, precision medicine, and clinical epidemiology, contributing to strengthened drug management standards and innovative therapeutic approaches adopted within hospital systems. Beyond research, his service as an expert reviewer for scientific and medical grant agencies reflects his influence on strategic research funding and healthcare innovation. Collectively, his academic output, professional leadership, and cross-disciplinary engagements underscore a career dedicated to advancing pharmacy practice, promoting rational drug use, and supporting the evolution of modern clinical pharmacology to benefit patients and healthcare systems. The researcher has 8 citations from 8 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Xue, W. (Year). Distribution and antibiotic resistance of pathogens in post-earthquake traumatic infections: A systematic review and meta-analysis.

Sulymon Saka | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Sulymon Saka | Infectious Diseases | Best Researcher Award

Resident doctor | Irrua Specialist Teaching Hospital | Nigeria

Dr. Sulýmon Ayobami Saka is an emerging Nigerian physician-scientist whose research bridges clinical medicine, audiology, infectious disease epidemiology, and the integration of artificial intelligence in healthcare. Trained at Ambrose Alli University with first-class honours equivalent in Medicine and Surgery, he has established a distinguished record of multidisciplinary research that spans global health, otolaryngology, and data-driven clinical innovation. His academic contributions include multiple peer-reviewed publications in high-impact journals such as BMC Infectious Diseases, BMC Public Health, and the Journal of Otolaryngology – Head & Neck Surgery, reflecting his commitment to evidence-based advancement in medicine. Dr. Saka’s research experience extends across several international collaborations, including the Bernhard Nocht Institute for Tropical Medicine in Germany and Sleep & Cradle® Solutions in the United States, where he contributes to studies on Lassa fever vaccine development, digital maternal and paediatric health, and long-term sequelae of infectious diseases. His scientific works emphasize the intersection of technology and clinical care—exploring how artificial intelligence, digital health platforms, and precision diagnostics can improve health outcomes in low- and middle-income settings. Recognized with multiple awards, including the ECOWAS Lassa Fever International Conference Scholarship and the Newcastle University Vice-Chancellor’s International Scholarship, Dr. Saka exemplifies a new generation of African medical researchers advancing global scientific dialogue. Through his leadership in research and mentorship, he continues to contribute to projects that not only enhance disease surveillance and clinical epidemiology but also foster equitable access to healthcare innovations. His work underscores a vision for a future where interdisciplinary science, cross-border collaboration, and artificial intelligence converge to transform patient care and strengthen health systems across the developing world. He has 9 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Sibomana, O., Saka, S. A., Grace Uwizeyimana, M., Mwangi Kihunyu, A., Obianke, A., Oluwo Damilare, S., Bueh, L. T., Agbelemoge, B. O. G., & Omoefe Oveh, R. (2025). Artificial Intelligence–Assisted Endoscopy in Diagnosis of Gastrointestinal Tumors: A Review of Systematic Reviews and Meta-Analyses. Gastro Hep Advances.

2. Blackie, F. F., Saka, S. A., Ikhifa, C. E., Okechukwu, E. J., & Agbonifo, M. (2025). Aural Myiasis in a Retroviral-Positive Nigerian Child: A Rare Case of Extensive Ear Infestation. Research Square.

3. Emekolom, O. N., Oladipupo, E. O., Saka, S. A., Ojo, D. O., Edhugo, S. E., Olayinka, A. J., & Aremu-Cole, A. H. (2025). Compliance with Universal Standard Precautions and Perceived Influencing Factors among Nurses in a Tertiary Institution in Edo State, Nigeria. Asian Journal of Research in Nursing and Health.

4. Akhigbe, M. E., Saka, S. A., Ighodaro, O., Ghouse, M. A., Emekolom, O. N., & Okoro, O. V. (2025). Doctors’ Knowledge, Attitudes and Prescription Practices on Antibiotic Use: A Study in a Suburban Tertiary Hospital in Nigeria. BMC Health Services Research.

5. Saka, S. A., Ojo, D. O., Mezu, N. M., Uzuegbu, C. O., Ighodaro, O., Illoh, O. O., Emekolom, O. N., Akpa, O. A., Obiora, E. A., & Muogbo, A. P. (2025). Knowledge, Perception and Preventive Practices of Lassa Fever Among Mothers of Under-Five Children in an Endemic Community in Edo State, Nigeria. Research Square.

Mohammad Mehdi Akbarin | Virology | Best Researcher Award

Published on by Health Scientists

Dr. Mohammad Mehdi Akbarin | Virology | Best Researcher Award 

Postdoctoral Fellow | UNAM | Mexico

Dr. Mohammad Mehdi Akbarin is a distinguished Iranian immunologist and molecular virologist whose academic and research pursuits bridge medical immunology, viral oncology, and immunogenetics. Currently serving as a Postdoctoral Fellow in Virology at the Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México (FESC–UNAM), his work focuses on understanding genetic variations that influence susceptibility and resistance to Bovine Leukemia Virus infection in cattle, contributing to translational advancements in comparative immunovirology. He earned his Ph.D. and M.Sc. in Medical Immunology from Mashhad University of Medical Sciences, where his pioneering research on HTLV-1 molecular pathogenesis, recombinant antigen development, and immunotherapeutic target design laid a foundation for novel diagnostic and therapeutic strategies against viral-associated malignancies such as Adult T-cell Leukemia/Lymphoma. Dr. Akbarin has authored and co-authored numerous peer-reviewed publications in high-impact international journals, covering areas such as cell signaling, host-virus interactions, and immune regulatory mechanisms, while also contributing to scientific books on human T-lymphotropic viruses and related diseases. His interdisciplinary collaborations span institutions across Iran, South Korea, and Mexico, underscoring his global engagement in biomedical research. Beyond his scholarly output, he has played instrumental roles in organizing international scientific congresses and mentoring medical and laboratory science students in immunology, bacteriology, and molecular diagnostics. His contributions to immunogenetics and translational virology have advanced the understanding of viral immune modulation and disease progression, reinforcing the link between molecular research and public health applications. Dr. Akbarin’s scientific vision centers on developing integrative molecular approaches for infectious disease control, cancer immunotherapy, and system biology-driven therapeutic innovation, embodying a commitment to advancing medical science and improving global health outcomes through precision immunology. He has 120 citations from 19 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Tarokhian, H., Rahimi, H., Mosavat, A., Shirdel, A., Rafatpanah, H., Akbarin, M. M., et al. (2018). HTLV-1–host interactions on the development of adult T cell leukemia/lymphoma: Virus and host gene expressions.

2. Akbarin, M. M., Rahimi, H., HassanNia, T., Razavi, G. S., Sabet, F., & Shirdel, A. (2013). Comparison of HTLV-I proviral load in adult T cell leukemia/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers.

3. Ramezani, S., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Tarokhian, H., et al. (2017). Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma. Medical Microbiology and Immunology

4. Akbarin, M. M., Shirdel, A., Bari, A., Mohaddes, S. T., Rafatpanah, H., Karimani, E. G., et al. (2017). Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients. Blood Research.

5. Jafarian, M., Mozhgani, S. H., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., et al. (2017). Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated.

Christianah Ibironke Odita | Epidemiology | Best Researcher Award

Published on by Health Scientists

Dr. Christianah Ibironke Odita | Epidemiology | Best Researcher Award 

Research Officer | National Veterinary Research Institute, Vom | Nigeria

Dr. Christianah Ibironke Odita is a distinguished Chief Veterinary Research Officer and Head of the Division of Veterinary Public Health and Preventive Medicine at the National Veterinary Research Institute (NVRI), Vom, Nigeria. She holds a Ph.D. in Veterinary Science from the University of Pretoria, South Africa, an M.Sc. in Veterinary Epidemiology and Public Health from the Royal Veterinary College, University of London, and a Master of Veterinary Public Health (MVPH) as well as a Doctor of Veterinary Medicine (DVM) from the University of Ibadan, Nigeria. Her research focuses on the epidemiology and control of infectious and zoonotic diseases, particularly at the human–animal interface, with specialization in disease surveillance, risk modeling, outbreak investigation, and preventive medicine. Dr. Odita has authored and co-authored several impactful publications in reputed journals, including Vaccine, One Health Outlook, Nigerian Veterinary Journal, and Open Veterinary Journal. Her scholarly contributions span critical studies on rabies, avian influenza, anthrax, and antimicrobial resistance in poultry, emphasizing evidence-based strategies for public health policy and disease prevention. She is a Commonwealth Scholar and a recipient of the Epix Analytics One Risk Course Awards for excellence in report writing and presentation, as well as the NVRI Research Grant Award. Dr. Odita continues to contribute to advancing veterinary epidemiology and public health through research, mentorship, and active engagement in collaborative One Health initiatives across Africa. She has 7 citations from 4 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Akanbi, O. B., Alaka, O. O., Olaifa, O. S., Meseko, C. A., Inuwa, B., Ohore, O. G., Tijani, M., Jarikre, T., Ola, O., & Odita, C., et al. (2024). Pathology and molecular detection of influenza A subtype H9N2 virus in commercial poultry in Nigeria. Open Veterinary Journal.

2. Odita, C. I., Conan, A., Smith-Antony, M., Battice, J., England, S., Barry, D., Gessner, B. D., & Knobel, D. L. (2022). Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial. Vaccine.

3. Knobel, D., Odita, C. I., Conan, A., Barry, D., Smith-Anthony, M., Battice, J., England, S., & Gessner, B. D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial. Trials.

4. Odita, C. I., Conan, A., Barry, D., Smith-Antony, M., Battice, J., England, S., Gessner, B. D., & Knobel, D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial.

Aneta Pluta | Virology | Best Infectious Disease Researcher Award

Published on by Health Scientists

Dr. Aneta Pluta | Virology | Best Infectious Disease Researcher Award

Assistant Professor | National Veterinary Research Institute | Poland

Dr. Aneta Katarzyna Pluta, PhD, serves as an Assistant Professor in the Department of Biochemistry and Omics Analyses at the National Veterinary Research Institute (NVRI), Puławy, Poland, where she has been employed since 2010. She earned her PhD in Veterinary Sciences from NVRI in 2022, following her MSc in Microbiology and a Postgraduate Specialization in Medical Analytics from the Medical University of Lublin. Additionally, she completed a specialization in the Psychology of Social Communication at Maria Curie-Skłodowska University. Dr. Pluta’s research focuses on veterinary virology and molecular biology, particularly the genomics, pathogenesis, and diagnostics of Bovine Leukemia Virus (BLV). Her work encompasses qPCR harmonization, next-generation sequencing (NGS/RNA-seq), and viral gene regulation, contributing to international collaborative studies and the WOAH (OIE) Enzootic Bovine Leukosis Reference Laboratory. She has authored numerous impactful papers in journals such as Scientific Reports, Pathogens, Retrovirology, and Viruses, advancing understanding of BLV molecular variability and host–virus interactions. As Principal Investigator of an NCN PRELUDIUM grant, she explored the effects of BLV genomic mutations on viral replication. Her scholarly excellence has earned her multiple distinctions, including the Polish Society of Veterinary Science Main Award, NVRI Scientific Council Honorable Mention, and presentation awards from DIAGMOL and All Things BLV. Dr. Pluta also contributes to the global scientific community as a peer reviewer for several international journals and as the initiator of the Breast Cancer–BLV Research Network, fostering interdisciplinary collaboration in veterinary and medical virology. She has 325 citations from 23 documents with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publications

1. Pluta, A., Rola-Łuszczak, M., Hoffmann, F. G., Donnik, I., Petropavlovskiy, M., & Kuźmak, J. (2024). Genetic variability of bovine leukemia virus: Evidence of dual infection, recombination and quasi-species.

2. Rola-Łuszczak, M., Sakhawat, A., Pluta, A., Ryło, A., Bomba, A., Bibi, N., & Kuźmak, J. (2021). Molecular characterization of the env gene of bovine leukemia virus in cattle from Pakistan with NGS-based evidence of virus heterogeneity.

3. Pluta, A., Blazhko, N. V., Ngirande, C., Joris, T., Willems, L., & Kuźmak, J. (2021). Analysis of nucleotide sequence of Tax, miRNA and LTR of bovine leukemia virus in cattle with different levels of persistent lymphocytosis in Russia.

4. Pluta, A., Jaworski, J. P., & Cortés-Rubio, C. N. (2020). Balance between retroviral latency and transcription: Based on HIV model.

5. Pluta, A., Willems, L., Douville, R. N., & Kuźmak, J. (2020). Effects of naturally occurring mutations in bovine leukemia virus 5′-LTR and Tax gene on viral transcriptional activity.

Veena Kumari HB | Medical Microbiology | Best Researcher Award

Published on by Health Scientists

Dr. Veena Kumari HB | Medical Microbiology | Best Researcher Award

Professor | National Institute of Mental Health and Neurosciences | India

Dr. Veena Kumari HB is a distinguished Professor in the Department of Neuromicrobiology at NIMHANS, Bangalore, with extensive expertise in the diagnosis, management, and research of central nervous system (CNS) infections. She completed her Doctorate in Microbiology and has since established herself as a leading clinician-scientist, combining rigorous laboratory research with translational clinical studies. Her key research areas encompass bacterial and fungal brain infections, ventriculitis, meningitis, methicillin-resistant Staphylococcus aureus (MRSA), Cryptococcus species, and COVID-19-associated neurological complications, with a strong focus on molecular characterization, epidemiology, and infection control strategies. Dr. Veena Kumari has an impressive publication record, including high-impact contributions such as her multivariate biomarker study in ventriculitis (Scientific Reports, 2025), investigations into device-associated meningitis and linezolid-resistant pathogens, and extensive analyses of CNS cryptococcosis across pre- and post-HIV eras. She has also led and contributed to several major research projects funded by ICMR, SERB, and institutional grants, exploring diagnostic innovations, antifungal susceptibility, and microbial population dynamics. In recognition of her scientific excellence, she has received numerous honors for her contributions to medical microbiology and neurology, and she actively serves as a reviewer and editorial board member for prominent journals in infectious diseases and microbiology. Dr. Veena Kumari HB’s career reflects a rare integration of clinical acumen, research rigor, and mentorship, positioning her as a transformative leader in the field of neuromicrobiology and infectious disease research in India and globally.

Profile: Google Scholar

Featured Publications

1. Kumari, H. B. V., Nagarathna, S., & Chandramuki, A. (2007). Antimicrobial resistance pattern among aerobic gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre.

2. Srinivas, D., HB, V. K., Somanna, S., Bhagavatula, I., & Anandappa, C. B. (2011). The incidence of postoperative meningitis in neurosurgery: An institutional experience. Neurology India.

3. Chandramuki, A., Lyashchenko, K., Kumari, H. B. V., Khanna, N., Brusasca, P. N., … (2002). Detection of antibody to Mycobacterium tuberculosis protein antigens in the cerebrospinal fluid of patients with tuberculous meningitis.

4. Kulkarni, G. B., Pal, P. K., Kumari, H. B. V., Goyal, M., Kovoor, J. M. E., Nadig, S., … (2009). Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis with myelitis: A rare occurrence with diverse presentation.

5. Dhandapani, S., Rajshekar, D., Priyadarshi, K., Krishnamoorthi, S., … (2023). Comparison of hand hygiene compliance among healthcare workers in intensive care units and wards of COVID-19: A large-scale multicentric study in India.

Imen Larbi | Virology | Best Academic Researcher Award

Published on by Health Scientists

Dr. Imen Larbi | Virology | Best Academic Researcher Award

Researcher | Institut Pasteur de Tunis | Tunisia

Dr. Imen Larbi, a distinguished Doctor of Veterinary Medicine, currently serves as the Head of the Veterinary and Microbiology Laboratory at the Institut Pasteur de Tunis, Tunisia, where she leads innovative research on infectious and zoonotic diseases. She earned her Doctorate in Veterinary Medicine from the National School of Veterinary Medicine, Sidi Thabet, and later completed a PhD in Biological Sciences at the University of Tunis El Manar, focusing on the epidemiological surveillance of avian influenza virus in Tunisia. With over 15 years of professional experience, Dr. Larbi has developed deep expertise in animal health, zoonotic disease control, food safety, biosafety, and epidemiological surveillance. Her prolific research record includes publications in high-impact journals such as Virus Research, Virology Journal, Poultry Science, and Archives of Virology, addressing viral phylogenetics, zoonotic transmission, and public health risks. She has contributed significantly to international projects supported by the FAO, CDC, and U.S. Civilian Research Program, strengthening influenza surveillance and control programs in North Africa. A Certified Professional in Biorisk Management by the IFBA, she is a recognized expert serving on the National Committee of Experts in Animal Health and the Governing Board of the Institut Pasteur de Tunis. Her leadership and scientific excellence have earned her recognition in global veterinary and biosafety circles. In addition to her research and advisory contributions, Dr. Larbi actively participates in editorial and peer review activities for scientific journals, advancing veterinary microbiology and zoonotic disease research worldwide. She has 207 citations from 21 documents with an h-index of 7.

Profile: Scopus 

Featured Publications

1.Imen Larbi, (2025). Tracing the 2021 equine influenza outbreak: First characterization and phylogeographic analysis of H3N8 Florida clade 1 virus in Tunisia. Virology.

2. Imen Larbi, (2025). West Nile virus antibody prevalence in horses during the 2023 outbreak in Tunisia, North Africa. Vector Borne and Zoonotic Diseases.